|
1
|
Guideline for Gastric Cancer Treatment in
Japan. Japanese Gastric Cancer Association; 2nd edition. Tokyo:
2004
|
|
2
|
Guideline for Gastric Cancer Treatment in
Japan. Japanese Gastric Cancer Association; 3rd edition. Tokyo:
2010
|
|
3
|
National Institutes of Health Consensus
Development Conference Statement: adjuvant therapy for breast
cancer, November 1–3, 2000. J Natl Cancer Inst. 93:979–989.
2001.
|
|
4
|
Goldhirsch A, Glick JH, Gelber RD, Coates
AS and Senn HJ: Meeting highlights: International Consensus Panel
on the Treatment of Primary Breast Cancer. Seventh International
Conference on adjuvant therapy of primary breast cancer. J Clin
Oncol. 19:3817–3827. 2001.
|
|
5
|
Mukai M, Sato S, Komatsu N, Nishida T,
Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between
occult neoplastic cells in the lymph node sinuses and recurrence in
patients with curatively resected Dukes’ B colorectal cancer. Oncol
Rep. 10:1177–1181. 2003.PubMed/NCBI
|
|
6
|
Mukai M, Sato S, Komatsu N, Nishida T,
Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between
occult neoplastic cells in the lymph node sinuses and recurrence in
patients with Dukes’ C colorectal cancer. Oncol Rep. 10:1165–1169.
2003.
|
|
7
|
Mukai M, Sato S, Nakasaki H, Tajima T,
Saito Y, Nishiumi N, Iwasaki M, Tokuda Y, Ogoshi K, Inoue H and
Makuuchi H: Occult neoplastic cells in the lymph node sinuses and
recurrence of primary breast, lung, esophageal, and gastric cancer.
Oncol Rep. 11:81–84. 2004.PubMed/NCBI
|
|
8
|
Mukai M, Sato S, Komatsu N, Kimura T,
Ninomiya H, Kawada M, Nakasaki H, Ogoshi K and Makuuchi H: Accuracy
of criteria for predicting recurrence and metastasis in stage II
and III gastric cancer patients with lymph node metastasis. Oncol
Rep. 12:63–66. 2004.PubMed/NCBI
|
|
9
|
Mukai M, Sato S, Kimura T, Komatsu N,
Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Criteria for
predicting the recurrence and metastasis of stage I and II gastric
cancer without lymph node metastasis. Oncol Rep. 12:59–62.
2004.PubMed/NCBI
|
|
10
|
Mukai M, Tajima T, Sato S, Ninomiya H,
Wakui K, Komatsu N, Tsuchiya K, Nakasaki H and Makuuchi H:
Recurrence and 5-FU sensitivity of stage II/III node-positive
gastric cancer with occult neoplastic cells in lymph node sinuses.
Oncol Rep. 14:1505–1510. 2005.
|
|
11
|
Mukai M, Sato S, Tajima T, Ninomiya H,
Wakui K, Komatsu N, Tsuchiya K, Nakasaki H and Makuuchi H:
Recurrence and 5-FU sensitivity of stage I/II node-negative breast,
lung, or gastric cancer with occult neoplastic cells in lymph node
sinuses. Oncol Rep. 15:815–820. 2006.PubMed/NCBI
|
|
12
|
Mukai M, Sato S, Ninomiya H, Wakui K,
Komatsu N, Matsui N, Nakamura M, Nakasaki H and Makuuchi H:
Sensitivity to CPT-11 and platinum derivatives of stage I/II
node-negative breast, lung, and gastric cancer with occult
neoplastic cells in lymph node sinuses. Oncol Rep. 18:33–39.
2007.PubMed/NCBI
|
|
13
|
Mukai M, Sato S, Ninomiya H, Wakui K,
Komatsu N, Matsui N, Nakamura M, Ogoshi K and Makuuchi H:
Sensitivity to CPT-11 and platinum derivatives of stage II/III
node-positive gastric cancer with occult neoplastic cells in lymph
node sinuses. Ann Cancer Res Ther. 15:22–26. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sekido Y, Mukai M, Kishima K, Tajima T,
Hoshikawa T, Nakamura M, Nakamura N and Ogoshi K: Occult neoplastic
cells in the lymph node sinuses and recurrence/metastasis of stage
II/Dukes’ B colorectal cancer. Oncol Rep. 25:69–73. 2011.PubMed/NCBI
|
|
15
|
Sekido Y, Mukai M, Kishima K, Tajima T,
Hoshikawa T, Nakamura M, Nakamura N and Ogoshi K: Occult neoplastic
cells in the lymph node sinuses and recurrence/metastasis of stage
III/Dukes’ C colorectal cancer. Oncol Rep. 25:915–919.
2011.PubMed/NCBI
|
|
16
|
Sobin L, Gospodarowicz M and Wittekind C:
TNM classification of malignant tumors. 7th edition. John Wiley and
Sons, Ltd; New York: 2009
|
|
17
|
Nakane PK and Pierce GB Jr: Enzyme-labeled
antibodies: preparation and application for localization of
antigens. J Histochem Cytochem. 14:929–931. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakane PK and Pierce GB Jr: Enzyme-labeled
antibody for the light and electron microscopic localization of
tissue antigens. J Cell Biol. 33:307–318. 1967. View Article : Google Scholar
|
|
19
|
Greenson JK, Isenhart CE, Rice R, Mojzisik
C, Houchens D and Martin EW Jr: Identification of occult
micrometastases in pericolic lymph nodes of Duke’s B colorectal
cancer patients using monoclonal antibodies against cytokeratin and
CC49. Correlation with long-term survival. Cancer. 73:563–569.
1994.PubMed/NCBI
|
|
20
|
Nicholson AG, Marks CG and Cook MG: Effect
on lymph node status of triple levelling and immunohistochemistry
with CAM 5.2 on node negative colorectal carcinomas. Gut.
35:1447–1448. 1994. View Article : Google Scholar
|
|
21
|
Isaka N, Nozue M, Doi M and Fukao K:
Prognostic significance of perirectal lymph node micrometastases in
Dukes’ B rectal carcinoma: an immunohistochemical study by CAM5.2.
Clin Cancer Res. 5:2065–2068. 1999.PubMed/NCBI
|
|
22
|
Prandi M, Lionetto R, Bini A, Francioni G,
Accarpio G, Anfossi A, Ballario E, Bacchi G, Bonilauri S, Carobbi
A, et al: Prognostic evaluation of stage B colon cancer patients is
improved by an adequate lymphadenectomy: results of a secondary
analysis of a large scale adjuvant trial. Ann Surg. 235:458–463.
2002. View Article : Google Scholar
|
|
23
|
Mukai M, Ito I, Mukoyama S, Tajima T,
Saito Y, Nakasaki H, Sato S and Makuuchi H: Improvement of 10-year
survival by Japanese radical lymph node dissection in patients with
Dukes’ B and C colorectal cancer: A 17-year retrospective study.
Oncol Rep. 10:927–934. 2003.PubMed/NCBI
|
|
24
|
Nelson H, Petrelli N, Carlin A, Couture J,
Fleshman J, Guillem J, Miedema B, Ota D and Sargent D: Guidelines
2000 for colon and rectal cancer surgery. J Natl Cancer Inst.
93:583–596. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
JSCCR Guidelines for the Treatment of
Colorectal Cancer. Japanese Society for Cancer of the Colon and
Rectum (JSCCR); Tokyo: 2009
|
|
26
|
Makuuchi M and Sugihara K: Surgery of the
Colon, Rectum and Anus. 2nd edition. Knacks and Pitfalls. Bunkoudou
Co, Ltd; Tokyo: 2004
|
|
27
|
Ito I, Mukai M, Ninomiya H, Kishima K,
Tsuchiya K, Tajima T, Oida Y, Nakamura M and Makuuchi H: Comparison
between intravenous and oral postoperative adjuvant
immunochemotherapy in patients with stage II colorectal cancer.
Oncol Rep. 20:1189–1194. 2008.
|
|
28
|
Ito I, Mukai M, Ninomiya H, Kishima K,
Tsuchiya K, Tajima T, Nakamura M and Makuuchi H: Comparison between
intravenous and oral postoperative adjuvant immunochemotherapy in
patients with stage III colorectal cancer. Oncol Rep. 20:1521–1526.
2008.
|
|
29
|
Rosai J: Rosai and Ackerman’s Surgical
Pathology. 9th edition. Mosby; St. Louis, MO: pp. 670–671. pp.
817–818. 2004
|
|
30
|
Inada K, Shimokawa K, Ikeda T, Hayashi M
and Azuma S: Development of liver metastasis in colorectal
carcinoma. With special reference to venous invasion and basement
membrane laminin. Acta Pathol Jpn. 41:240–245. 1991.
|
|
31
|
Japanese Classification of Gastric
Carcinoma. Japanese Gastric Cancer Association; 14th edition.
Tokyo, Japan: 2010
|
|
32
|
Muta H, Noguchi M, Kanai Y, Ochiai A,
Nawata H and Hirohashi S: E-cadherin gene mutations in signet ring
cell carcinoma of the stomach. Jpn J Cancer Res. 87:843–848. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mayer B, Johnson JP, Leitl F, Jauch KW,
Heiss MM, Schildberg FW, Birchmeier W and Funke I: E-cadherin
expression in primary and metastatic gastric cancer:
down-regulation correlates with cellular dedifferentiation and
glandular disintegration. Cancer Res. 53:1690–1695. 1993.
|
